Kurtz, Marcel http://orcid.org/0000-0002-2244-6025
Mohring, Pia
Förster, Katharina
Bauer, Michael
Kanske, Philipp http://orcid.org/0000-0003-2027-8782
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KA 4412/2-1, KA 4412/4-1, KA 4412/5-1, SFB940/3 C07)
Technische Universität Dresden
Article History
Received: 16 September 2020
Accepted: 11 February 2021
First Online: 3 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: Michael Bauer serves as a consultant to Janssen-Cilag, neuraxpharm, Novartis, Shire International, and Takeda, and receives fees from Aristo, Hexal, Janssen-Cilag, and Sunovion, outside the submitted work.